Attachment_A_-Specimen_Test_List__11-4-15_DRAFT.pdf

ATTACHMENT A-SPECIMEN TEST LIST (Estimated Test List subject to change due to programmatic requirements; see PWS)

Location

Estimated

Volume Bldg 10, RM 2C324

# Test Name (12 months) Turnaround Time Methodology daily, after 3pm

1 1,25-Dihydroxyvitamin D, Serum 1828 2 days Cartridge Extraction/LC-MS/MS x

2 11-Deoxycortisol, Serum 1 3 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

11-Desoxycortisol (Spec. Compound

S) 1 2 - 5 days Mass Spectrometry (LC/MS/MS) x

4 14-3-3 Protein, CSF 1 2 days Immunochemiluminometric Assay x

5 17-Hydroxypregnenolone, Serum 2 2 days Liquid Chromatography- Tandem Mass Spectrometry (LC-

MS/MS)

x

6 17-Hydroxyprogesterone, Serum 1 2 days High Performance Liquid Chromatography-Tandem Mass

Spectrometry (LC/MS/MS) x

7 17-Hydroxyprogesterone, Serum 1 2 days High Performance Liquid Chromatography-Tandem Mass

Spectrometry (LC/MS/MS) x

8 21-Deoxycortisol, Serum 1 3 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

9 21-Hydroxylase Antibody, Serum 50 2 days Immunoabsorption Assay x

25-Hydroxyvitamin D2 and D3, Serum 1 2 days

Liquid Chromatography/Tandem Mass Spectrometry (LC-

MS/MS)

x

5,10-Methylenetetrahydrofolate

Reductase C677T, Mutation, Blood 1 3 days Direct Mutation Analysis by the Invader assay x

12 5-Flucytosine, Serum 9 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

5-HIAA (5-Hydroxyindoleacetic Acid), Random Urine 1 3 - 7 days

High Performance Liquid Chromatography, Electrochemical Detection x

5-Hydroxyindoleacetic Acid (5-HIAA), Urine 411 2 days

Liquid chromatography-tandem mass spectrometry (LC-

MS/MS)

x

15 5'Nucleotidase 36 1 -2 days Enzymatic x

16 Acetominophen, Serum 6 Same day/1 day Photometric x

17 Acetoacetate 0 3 days Gas Chromatography (GC) x

Myasthenia Gravis Evaluation, Pediatric 57 3 days Radioimmunoassay (RIA) x

Myasthenia Gravis Evaluation, Pediatric 5 3 days Radioimmunoassay (RIA) x

20 Acetylcholinesterase, Erythrocytes 1 4 days Spectrophotometric-Thiocholine Production x

21 Acid-Fast Smear for Mycobacterium 1 1 day Auramine-Rhodamine Stain x

22 Acylcarnitine, QN, Plasma 76 2 days Electrospray Ionization Tandem Mass Spectrometry (ESI-

MS/MS)

x

23 Acylglycines, QN, Urine 9 5 days Gas Chromatography/Mass Spectrometry (GC/MS) x

ADAMTS13 Activity and Inhibitor

Profile

ADAMTS13 Activity

Assay: 24 hours/ADAMTS13

Inhibitor Assay: 3-

5 days/ADAMTS13

Bethesda Titer: 3-5 days

Fluorescence Resonance Energy Transfer (FRET) x

25 Additional Identification Procedure 1 Variable Variable x

26 Additional Testing Virus Ident 1 Variable Variable x

27 Adenosine Deaminase, Blood 0 1 day Colorimetric (C), Kinetic x

ADENOSINE DEAMINASE (ADA) -

FLUID

0 2 days Ultraviolet spectrophotometry x

Adenovirus Antibody by Complement

Fixation 144 2 - 5 days Complement Fixation x

Adenovirus Antigen Detection, Gastroenteritis, EIA 20 1 - 4 days Enzyme Immunoassay (EIA) x

Adenovirus DNA, Quantitative, Real

Time PCR 1 1 - 3 days Polymerase Chain Reaction (PCR) x

32 Adenovirus DNA by Rapid PCR 1 2 - 3 days Real-Time Polymerase chain Reaction (PCR)/DNA Probe

Hybridization x

Adenovirus, Molecular Detection, PCR, Plasma 1 2 - 3 days

Real-Time Polymerase Chain Reaction (PCR)/DNA Probe

Hybridization x

34 Adiponectin 1 3 days ELISA x

35 ADmark Phospho-Tau/Total-Tau/Ab42 1 14 - 21 days Enzyme Linked Immunosorbent Assay (ELISA) x

Adrenocorticotropic Hormone (ACTH), Plasma 1 Same day/1 day Automated Chemiluminescent Immunometric Assay x

37 Aeroallergen Screen 1 2 days ImmunoCAP FEIA Immulite 2000 x

38 Aerobe Ident by Sequencing 2 x

Alanine Aminotransferase (ALT)

(GPT), Serum 5 Same day/1 day Photometric Rate, L-alanine with Pyridoxal -5- Phosphate x

Albumin Immunofluorescent Stain, Renal 1 1 day Immunohistology (Immunofluorescence) x

41 Aldolase, Serum 1 1 day Ultraviolet, Kinetic x

42 Aldosterone, 24 Hour, Urine 125 2 days High-Performance Liquid Chromatography/Tandem Mass

Spectrometry (LC-MS/MS) x

43 Aldosterone, Inferior Vena Cava 1 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

44 Aldosterone, Left Adrenal Vein 1 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

45 Aldosterone, Right Adrenal Vein 1 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

46 Aldosterone, Serum 219 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

47 Alert Specimen Charge MML 4 - N/A x

Alkaline Phosphatase, Total and

Isoenzymes, Serum 4 2 days

Photometric, P-Nitrophenol Phosphate/ Electrophoresis, Densitometry x

Allergic Bronchopulmonary

Aspergillosis Panel II 1 3 - 5 days

ImmunoCAP 1000

ImmunoCAP FEIA

Enzyme immunoassay (FEIA) x

50 Allergen (IgE), Almond 2 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

51 Alpha-1-Acid glycoprotein 1 2 - 6 days Fixed Rate Time Nephelometry x

Alpha-1-Antitrypsin Clearance, Feces

& Serum 7 Same day/1 day Nephelometry x

53 !Alpha-1-Antitrypsin Deficiency Profile 1 2 days PCR/Nephelometry x

54 Alpha-1-Antitrypsin, Random, Feces 11 1 day Nephelometry x

55 Alpha-1-Antitrypsin, Serum 2 Same day/1day Nephelometry x

Page 1 Attachment A -Specimen Test 11-4-15 DRAFT.xlsx

ATTACHMENT A-SPECIMEN TEST LIST (Estimated Test List subject to change due to programmatic requirements; see PWS)

Estimated

Volume Bldg 10, RM 2C324

# Test Name (12 months) Turnaround Time Methodology daily, after 3pm

56 Alpha-1-Microglobulin, Random, Urine 1 1 day

Only orderable as part of a profile. For further information see #84448 "Alpha-1-Microglobulin, Random, Urine."

x

57 Alpha-2-Macroglobulin, Serum 81 Same day/1 day Nephelometry x

58 Alpha-Fetoprotein (AFP), CSF 3 Same day/1 day Two-Site Immunoenzymatic (Sandwich) Assay x

59 Alpha-Fucosidase, Fibroblasts 1

30-45 days depending on rapidity of growth

Fluorometric x

60 Alpha-Gal Panel 1 1 - 2 days Fluorescence Enzyme Immunoassay (FEIA) x

61 Alpha-Galactosidase, Leukocytes 1 8 days Fluorometric x

62 Alpha-Globin Gene Analysis 2 8 days

Dosage Analysis by Polymerase Chain Reaction (PCR), Multiplex Ligation-Dependent Probe Amplification (MLPA) and Luminex Technology x

Alpha-Subunit Pituitary Tumor

Marker, Serum 164 1 day Immunochemiluminescent assay (ICMA) x

64 Allergen (IgE), Alternaria Tenuis 39 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

65 Aluminum, 24 Hour, Urine 1 1 day Dynamic Reaction Cell-Inductively Coupled Plasma-Mass

Spectrometry x

66 Aluminum, Random, Urine 1 1 day Dynamic Reaction Cell-Inductively Coupled Plasma-Mass

Spectrometry x

67 Aluminum, Serum 1 1 day Dynamic Reaction Cell-Inductively Coupled Plasma-Mass

Spectrometry x

Amino Acids, Maple Syrup Urine

Disease Panel, Plasma 1 3 days -4 days

Liquid Chromatography-tandem Mass Spectrometry (LC-

MS/MS)

x

69 Amino Acids Quantitative, Plasma 360 3 days - 4 days Liquid Chromatography-Tandem Mass Spectometry (LC-

MS/MS)

x

Amino Acids Quantitative, Random, Urine 208 3 - 4 days

Liquid chromatography-tandem mass spectrometry (LC-

MS/MS)

x

71 Amino Acids, Quantitative, CSF 3 3 days

Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS) x

Amino Acids, Urea Cycle Disorders

Panel, Plasma 1 3 days

Liquid Chromatography-tandem Mass Spectrometry (LC-

MS/MS)

x

73 Aminolevulinic Acid (ALA), Urine 1 3 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

74 Amiodarone, Serum 1 2 days High-Pressure Liquid Chromatography (HPLC) x

75 Amitriptyline and Nortriptyline, Serum 8 2 days High-Pressure Liquid Chromatography (HPLC) x

AMPA-Receptor Antibody by CBA, Serum 1 4 -7 days

Cell-Binding Assay (CBA) - Indirect Immunofluorescence

Assay (IFA) x

Amphetamines Confirmation, Chain of

Custody, Urine ($0.00)

Chain of Custody Processing (Bill

Only) ($0.00)

Adulterants Survey, Chain of Custody, Urine ($0.00)

2 days

Same day/1 day

Immunoassay/Gas Chromatography-Mass Spectrometry

(GC-MS) Confirmation with Quantitation x

78 Amphetamines Confirmation, Urine 1 2 days Immunoassay/Gas Chromatography-Mass Spectrometry

(GC-MS) Confirmation with Quantitation x

79 Amphiphysin Ab, CSF 1 if positive 5 days/if negative 3 days Indirect Immunofluorescence x

Amphiphysin Antibody Western Blot, Serum 1 4 days Western Blot x

81 Amylase, Isoenzymes 1 1 day Enzymatic x

82 Amylase, Pancreatic, Serum 1 1 day Monoclonal Antibody Technique x

Amyloid Protein Identification, Paraffin, LC MS/MS ($0.00)

Congo Red, Stain ($0.00)

7-15 days

10 days

Liquid chromatography-tandem mass spectrometry. x

84 Susceptibility, Anaerobic, MIC 3 1 day Minimum Inhibitory Concentration (MIC) by E Test x

85 Anaerobe Suscep per agent 5 1 - 2 days Minimum Inhibitory Concentration (MIC) x

Anaplasma phagocytophilum

Antibodies (IgG, IgM) 1 1-3 days Immunofluorescence Assay (IFA) x

87 Allergen (IgE), Anchovy 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

88 Androstanediol Glucuronide 1 3 - 17 days High Pressure Liquid Chromatography and Tandem Mass

Spectrometry (HPLC/MS-MS) x

89 Androstenedione, Serum 1 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

90 Androstenedione, Serum 1 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

91 Angiotensin Converting Enzyme, CSF 1 1 - 5 days Quantitative Spectrophotometry x

Angiotensin Converting Enzyme

(ACE), Serum 1 1 - 2 days Spectrophotometry (SP) x

93 ANGIOTENSIN I, PLASMA 1 5 - 7 working days RADIOIMMUNO ASSAY x

94 Angiotensin II, Plasma 3 7-10 days Direct Radioimmunoassay (RIA) x

Antibody to Extractable Nuclear

Antigen Evaluation, Serum 40 Same day/1 day Multiplex Flow Immunoassay x

96 Anti-DNase B Titer, Serum 1 Same day/1 day Nephelometry x

97 Anti-Enterocyte Antibodies 36 4 - 8 weeks x

98 Anti-IgA 1 5 - 8 days Enzyme-Linked Immunosorbent Assay (ELISA) x

99 Anti-IgE Receptor Antibody 7 - 9 days x

100 Antimullerian Hormone (AMH), Serum 122 1 day Immunometric assay x

Anti-Neuronal Nuclear Ab, Type 1, Serum

3 days if negative;

5 days if positive Indirect Immunofluorescence x

Anti-Neuronal Nuclear Ab, Type 2, Serum

3 days if negative;

5 days if positive Indirect Immunofluorescence x

Anti-Neuronal Nuclear Ab, Type 2, CSF

5 days if positive/3 days if negative Indirect Immunofluorescence x

Page 2 Attachment A -Specimen Test 11-4-15 DRAFT.xlsx

ATTACHMENT A-SPECIMEN TEST LIST (Estimated Test List subject to change due to programmatic requirements; see PWS)

Estimated

Volume Bldg 10, RM 2C324

# Test Name (12 months) Turnaround Time Methodology daily, after 3pm

Anti-Neuronal Nuclear Ab, Type 3, Serum

3 days if negative/5 days if positive Indirect Immunofluorescence x

Anti-Neuronal Nuclear Ab, Type 3, CSF

3 days if negative/5 days if positive Indirect Immunofluorescence (IFA) x

106 ANCA Panel for Vasculitis 1 3 days Multiplex Flow Immunoassay/Indirect

Immunofluorescence x

Antinuclear Antibodies (ANA), HEp-2

Substrate, Serum

1 day/2 days if positive Immunofluorescence Assay (IFA) x

Antinuclear Antibodies (ANA), IFA with Reflex to Connective Tissue

Disease Antibodies

1 day/2 days if positive Immunofluorescence Assay (IFA) x

109 Antinuclear Antibodies (ANA), Serum 3 1 day Enzyme-Linked Immunosorbent Assay (ELISA) x

110 ANA Titer and Pattern Reflex 9 1 day/2 days if positive Immunofluorescence Assay (IFA) x

111 Phosphaditylcholine Ab 1 1 - 9 days Enzyme-Linked Immunosorbent Assay (ELISA) x

112 Phosphatidylethanolamine Panel 1 1 - 9 days Enzyme-Linked Immunosorbent Assay (ELISA) x

113 Antistrep-O Titer, Serum 1 Same day/1 day Nephelometry x

114 Apolipoprotein E Genotyping, Blood 1 5 days Polymerase Chain Reaction (PCR) x

Arginine Vasopressin (ADH) (AVP), Plasma 42 3 days Radioimmunoassay (RIA) x

116 Arsenic Fractionation, 24 Hour, Urine 2 2 days Liquid-Liquid Extraction/Inductively Coupled Plasma-

Mass Spectrometry (ICP-MS) x

117 Arsenic, 24 Hour, Urine 7 1 day Inductively Coupled Plasma/Mass Spectrometry (ICP/MS) x

118 Arsenic, Blood 1 1 day Inductively Coupled Plasma/Mass Spectrometry (ICP/MS) x

119 Arsenic, Hair 1 2 days Inductively Coupled Plasma/Mass Spectrometry (ICP/MS) x

120 Arsenic, Nails 1 2 days Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) x

121 Arsenic, Random, Urine 1 1 day Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) x

122 Arylsulfatase A, Urine 1 9 days Colorimetric, Kinetic x

123 Arylsulfatase A, Fibroblasts 1

30-45 days depending on rapidity of growth

Colorimetric (Enzyme Assay), Cultivated from Biopsy as

Monolayer, Subculture cryopreservation, Storage x

124 Arylsulfatase A, Leukocytes 1 8 days Colorimetric, Kinetic x

125 Ascorbic Acid, Plasma 130 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

Ashkenazi Jewish Mutation Analysis

Without Cystic Fibrosis 1 3 days Polymerase Chain Reaction (PCR) x

Aspartate Aminotransferase (AST/

GOT), Serum 5 Same day/1 day Photometric, L-Aspartate with Pyridoxyl-5-Phosphate x

Aspergillus (Galactomannan) Antigen, Serum 64 1 day Enzyme Immunoassay (EIA) x

129 Aspergillus Precipitins, Serum 1 2 - 5 days Immunodiffusion (ID) x

Aspergillus Antigen, Bronchoalveolar

Lavage Fluid 162 1 day Enzyme immunoassay (EIA) x

131 Allergen (IgE), Aspergillus Fumigatus 10 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

Aspergillus Fumigatus, IgG

Antibodies, Serum 11 Same day/1 day Fluorescence Enzyme Immunoassay (FEIA) x

133 Allergen (IgE), Aspergillus niger 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

Autoimmune Liver Disease Panel, Serum 1 2 days

AMA: Enzyme Immunoassay (EIA)

SMA: Indirect Immunofluorescence

ANA2: Enzyme-Linked Immunosorbent Assay (ELISA) x

135 Allergen (IgE), Avocado 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

Azathioprine (Imuran) as 6-

Mercaptopurine 1 5 days x

137 Babesia Microti Antibodies (IgG, IgM) 1 1 - 4 days Immunofluorescence Assay (IFA) x

Babesia Microti IgG Antibodies, Serum 11 Same day/1 day Immunofluorescence Assay (IFA) x

Babesia species Molecular Detection, PCR, Blood 1 Same day/1 day

Real-Time Polymerase Chain Reaction (PCR)/DNA Probe

Hybridization x

Barbiturates Confirmation, Chain of

Custody, Urine 1 2 days

Immunoassay/Gas Chromatography-Mass Spectrometry

(GC-MS) Confirmation with Quantitation x

141 Barbiturates Confirmation, Urine 24 2 days Immunoassay/Gas Chromatography-Mass Spectrometry

(GC-MS) Confirmation with Quantitation x

142 Allergen (IgE), Barley 39 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

Bartonella Antibody Panel, IgG & IgM, Serum 37 Same day/1 day Immunoflourescence Assay (IFA) x

144 Bartonella by Rapid PCR 1 2 days Rapid Polymerase Chain Reaction (PCR) x

145 Bartonella PCR, Blood 3 2 days Rapid Polymerase Chain Reaction (PCR) x

BCR/ABL, mRNA Detection, Reverse

Transcription-PCR (RT-PCR), Qualitative, Diagnostic Assay

1 5 days Reverse Transcription-Polymerase Chain Reaction (RT-

PCR) with Fluorescent-Bead Array Analysis x

BCR/ABL, p190, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Assay

20 4 days Quantitative Reverse Transcription-Polymerase Chain

Reaction (RT-PCR) x

BCR/ABL1, p210, mRNA Detection, RT-

PCR, Quantitative, Monitoring Chronic

Myelogenous Leukemia (CML)

2 3 days Quantitative RT-PCR using GeneXpert (Cepheid) x

149 BCR/ABL, Translocation 9;22, D, FISH 1 7 days D-FISH with BCR/ABL. x

Page 3 Attachment A -Specimen Test 11-4-15 DRAFT.xlsx

ATTACHMENT A-SPECIMEN TEST LIST (Estimated Test List subject to change due to programmatic requirements; see PWS)

Estimated

Volume Bldg 10, RM 2C324

# Test Name (12 months) Turnaround Time Methodology daily, after 3pm

BCR/ABL, Tyrosine Kinase Inhibitor

Resistance, Kinase Domain Mutation

Screen

1 5 days

Reverse Transcription-Polymerase Chain Reaction (RT-

PCR) with

Fluorescent-Bead Array Analysis Allele-specific primer extension (ASPE) and detection by Luminex Bead array x

151 Allergen (IgE), Beef Regular Insulin 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

152 Allergen (IgE), Beef 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

Benzodiazepines Confirmation, Chain of Custody, Urine 1 2 days

Immunoassay/Gas Chromatography-Mass Spectrometry

(GC-MS) Confirmation with Quantitation x

154 Benzodiazepines Confirmation, Urine 3 2 days Immunoassay/Gas Chromatography-Mass Spectrometry

(GC-MS) Confirmation with Quantitation x

155 Beta Lactamase 3 x

Beta-2 Glycoprotein 1 Antibodies, IgG and IgM, Serum 125 Same day/1 day Enzyme-Linked Immunosorbent Assay (ELISA) x

157 Beta-2-Glycoprotein 1 Ab, IgG 1 Same day/1 day Enzyme Linked Immunosorbent Assay (ELISA) x

158 Beta-2-Glycoprotein 1 Ab, IgM 1 Same day/1 day Enzyme Linked Immunosorbent Assay (ELISA) x

Beta-2 Transferrin: Detection of

Spinal Fluid in Other Body Fluids 1 1 day

Electrophoresis/Immunofixation/Enzyme-immunodetection x

160 Beta-Carotene, Serum 59 2 days High-Performance Liquid chromatography (HPLC) x

161 Beta-CrossLaps (Beta-CTx), Serum 99 Same day/1 day Electrochemiluminescence x

162 Beta-Galactosidase, Fibroblasts 1

30-45 days depending on rapidity of growth

Fluorometric x

Beta-Human Chorionic Gonadotropin, Quantitative, Serum 238 1 day Electrochemiluminescence Immunoassay x

164 Beta-Hydroxybutyrate, Serum 1 Same day/1 day Photometric, B-Hydroxybutyrate Dehydrogenase (B-

HBDH)

x

Bile Acids, Fractionated and Total, Serum 16 2 days

Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

166 Bile Acids, Total, Serum 2 1 day Enzymatic x

167 Biotinidase, Serum 4 4 days Colorimetric x

BK (Polyoma) Virus by In Situ

Hybridization 1 1 day In situ Hybridizaion with BK Virus cRNA Probe x

BK Virus, Molecular Detection, PCR, Plasma 1 2 - 3 days

Real-time Polymerase Chain Reaction (PCR)/DNA Probe

Hybridization x

170 Blastomyces Antibody by EIA, Serum 1 1 day Enzyme Immunoassay (EIA) x

Blastomyces Antibody by

Immunodiffusion, Serum 1 2 days Immunodiffusion x

172 Bone Alkaline Phosphatase, Serum 191 1 day Immunoenzymatic assay x

Bordetella pertussis & parapertussis

Detection by Rapid PCR 2 1 day Multiplex Rapid PCR x

Bordetella pertussis Antibodies, IgA &

IgG by ELISA with Reflex to

Immunoblot

1 1 - 8 days Semi-Quantitative Enzyme-Linked Immunosorbent Assay with Qualitative Immunoblot, if appropriate x

Bordetella pertussis Antibody, IgA by

Immunoblot 1 1 - 18 days

Semi-Quantitative Enzyme-Linked Immunosorbent Assay with Qualitative Immunoblot, if appropriate x

Bordetella pertussis Antibody, IgG by

Immunoblot 1 1 - 18 days

Semi-Quantitative Enzyme-Linked Immunosorbent Assay with Qualitative Immunoblot, if appropriate x

BORDETELLA PERTUSSIS IGG

ANTIBODIES, MAID

1 1 - 4 days (MAID) Multi-Analyte Immunodetection x

Breast Carcinoma-Associated Antigen

(CA 27.29), Serum 56 Same day/1 day Chemiluminometric Immunoassay x

Brucella Antibody Screen, IgG and

IgM, Serum

Same day/1 day;

additional days if reflex testing required

Enzyme-Linked Immunosorbent Assay (ELISA) x

Brucella Total Antibody Confirmation, Agglutination, Serum 5 2 days Agglutination x

181 B-Type Natriuretic Peptide (BNP) 1 2 days Paramagnetic Particle, chemiluminescent Immunoassay x

Bullous Pemphigoid (BP) 180 & 230

IgG Antibodies, Serum

Same day/1 day

(Samples are tested 1 day/week)

Enzyme-Linked Immunosorbent Assay (ELISA) x

183 Busulfan, IV Dose, AUC, Plasma 10 Same day/1 day Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

184 C1 Esterase Inhibitor Antigen, Serum 3 1 day Nephelometry x

C1 Esterase Inhibitor, Functional

Assay, Serum 6 1 day Enzyme Immunoassay (EIA) x

186 C1Q Binding Assay 1 1 - 8 days Enzyme-Linked Immunosorbent Assay x

187 C1q Complement, Functional, Serum 4 Same day/1 day Lytic Activity x

C1q Paraffin Immunofluorescent

Stain, Renal 1 1 day Immunofluorescent staining using polyclonal antibodies. x

189 C1q, Immunofluorescent Stain, Renal 1 1 day Immunohistology (Immunofluorescence) x

190 C2 Complement, Antigen, Serum 2 5 days Radial Immunodiffusion x

191 C2 Complement, Functional, Serum 3 Same day/1 day CH(50) Automated Liposome Lysis Assay x

192 C3 Immunofluorescent Stain, Renal 1 1 day Immunohistology (Immunofluorescence) x

193 C5 Complement, Antigen, Serum 1 Same day/1 day Nephelometry x

194 Caffeine, Serum 1 Same day/1 day Enzyme-Multiplied Immunoassay Technique (EMIT) x

195 Calcitonin, FNAB, Lymph Node 1 Same day/1 day Immunoenzymatic Assay x

196 Calcitonin, Serum 615 Same day/1 day Automated Immunochemiluminometric Assay (ICMA) x

197 Calcium, 24 hour, Urine 1 1 day Inductively Coupled Plasma (ICP) Emission Spectroscopy x

Calcium/Creatinine Ratio, Random, Urine 1 1 day

Inductively Coupled Plasma-Optical Emission

Spectrometry; Enzymatic Colorimetric Assay x

199 Calprotectin 144 7 days Enzyme Linked Immunosorbent Assay (ELISA) x

200 Cancer Antigen 125 (CA 125), Serum 1 1 day Automated Immunoassay x

Page 4 Attachment A -Specimen Test 11-4-15 DRAFT.xlsx

ATTACHMENT A-SPECIMEN TEST LIST (Estimated Test List subject to change due to programmatic requirements; see PWS)

Estimated

Volume Bldg 10, RM 2C324

# Test Name (12 months) Turnaround Time Methodology daily, after 3pm

Cancer Antigen 15-3 (CA 15-3), Serum 1 1 day Electrochemiluminescence Immunoassay x

CANDIDA ANTIGEN AND ANTIBODY

PANEL

1 1 - 5 days ELISA and LA x

203 Carbamazepine Profile, Serum 27 Same day/1 day

Carbamazepine, Total, S: Immunoassay

Carb-10,11-Epoxide, S : High-Performance Liquid

Chromatography (HPLC)

Carbamazepine, Free, S: Ultrafiltration Followed by

Immunoassay x

Carbamazepine, Free and Total, Serum 1 Same day/1 day x

Carbohydrate Antigen 19-9 (CA19-9), Peritoneal Fluid 1 Same day/1 day Immunoenzymatic Assay x

Carbohydrate Antigen 19-9 (CA 19-

9), Pleural Fluid 1 Same day/1 day Immunoenzymatic Assay x

Carbohydrate Antigen 19-9 (CA 19-

9), Serum 1 Same day/1 day Chemiluminometric Immunoassay x

Carbohydrate Deficient Transferrin for

Congenital Disorders of Glycosylation

(CDG), Serum

59 5 days Affinity Chromatography/Mass Spectrometry (MS) x

Carbohydrate Deficient Transferrin, Adult, Serum 271 5 days Affinity Chromatography/Mass Spectrometry (MS) x

210 Carbohydrate, Urine 1 8 days Thin-Layer Chromatography (TLC), Qualitative x

Carboxy-Tetrahydrocannabinol (THC)

Confirmation, Chain of Custody, Urine 1 2 days

Immunoassay Gas Chromatography-Mass Spectrometry

(GC-MS)

x

Carboxy-Tetrahydrocannabinol (THC)

Confirmation, Urine 1 2 days

Immunoassay Gas Chromatography-Mass Spectrometry

(GC-MS)

x

Carcinoembryonic Antigen (CEA), Serum 1 Same day/1 day Chemiluminometric Immunoassay x

214 Carnitine, Plasma 1 2 days Tandem Mass Spectrometry (MS/MS) x

215 Carnitine, Serum 155 2 days Tandem Mass Spectrometry (MS/MS) x

216 Carnitine, Urine 1 2 days Tandem Mass Spectrometry (MS/MS) x

217 Allergen (IgE), Cashew 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

218 Allergen (IgE), Cat Epithelium 39 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

Catecholamine Fractionation, Urinary, Free 1042 2 days High-Pressure Liquid Chromatography (HPLC) x

Catecholamine Fractionation, Free, Random, Urine 81 2 days

RCTU: Enzymatic Colorimetric Assay

CATUR: High-Performance Liqiud Chromatography

(HPLC)

x

Catecholamine Fractionation, Plasma, Free 10 2 days High-Pressure Liquid Chromatography (HPLC) x

Celiac Disease Comprehensive

Cascade for Patients on a Gluten-Free

Diet

1 7 days Polymerse Chain Reaction x

223 Celiac Disease Serology Cascade 1 7 days Nephelometry x

224 Celiac-Associated HLA-DQ Typing 1 5 days Polymerase Chain Reaction (PCR)/Sequence-Specific

Oligonucleotide Probes (SSO) typing x

225 Centromere Antibodies, IgG, Serum 86 Same day/1 day Multiplex Flow Immunoassay x

Ceramide Trihexosides and Sulfatides, Urine 96 7 days

Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

227 CHIC2, 4q12 Deletion, FISH 1 6 days FISH for CHIC2 anomalies using bone marrow or peripheral blood x

228 Allergen (IgE), Chick Pea 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

Chikungunya Antibodies with

Reflex(es) to Titer 1 1 - 8 days Immunofluorescence Assay (IFA) x

230 Chikungunya IgG Titration 1 1 - 12 days Immunofluorescence Assay (IFA) x

231 Chikungunya IgM Titration 1 1 - 12 days Immunofluorescence Assay (IFA) x

232 Chlamydia Serology, Serum 2 Same day/1 day Micro-Immunofluorescent Antibody (MIF) Assay x

Chlamydia trachomatis and Neisseria gonorrhoeae by Nucleic Acid

Amplification (GEN-PROBE)

327 1 day Transcription Mediated Amplification x

234 Chlamydia trachomatis Culture 1 3 - 4 days Tissue Culture Immunoflouresence x

Chlamydia trachomatis, Miscellaneous

Sites, by Nucleic Acid Amplification

(GEN-PROBE)

5 1 day Transcription Mediated Amplification x

236 Chlordiazepoxide, Serum 1 Same day/1 day High-Pressure Liquid Chromatography (HPLC) x

237 Chloride, Body Fluids 1 Same day/1 day Indirect Ion-Selective Electrode/Coulometric. x

238 Chloride, Serum 9 Same day/1 day Potentiometric, Indirect Ion-Selective electrode. x

239 Cholecystokinin (CCK) 1 5 - 7 days Direct Radioimmunoassay (RIA) x

240 Cholestanol 1 3-5 working days x

241 Cholesterol, HDL, Serum 1 1 day enzymatic colorimetric x

242 Cholesteryl Esters, Serum 1 Same day/1 day Enzymatic Colorimetric x

Chorionic Gonad Beta-Subunit (HCG)

QN, CSF

3 1 day Electrochemiluminescent Immunoassay x

244 Chromatin (Nucleosomal) Antibody 1 1 day Immunoassay x

245 Chromium, Serum 1 1 day Dynamic Reaction Cell-Inductively Coupled-Mass

Spectrometry x

246 Chromogranin A, Serum 872 Same day/1 day Homogeneous Time-Resolved Fluorescence x

Chromosome Analysis, For Congenital

Disorders, Blood 3 10 days

Includes 2-banded karyotypes, analysis of 20 or more metaphases, and other techniques when required.

x

CIRCULATING IMMUNE COMPLEX

(CIC)

1 7 days ELISA x

Circulating Tumor Cells for Breast

Cancer by Cell Search, Blood 1 4 days Cell Search System x

Circulating Tumor Cells for Breast

Cancer by Cell Search, Blood 1 4 days Cell Search System x

Circulating Tumor Cells (CTC) for

Colorectal Cancer by CellSearch, Blood

1 4 days Cell Search System x

Page 5 Attachment A -Specimen Test 11-4-15 DRAFT.xlsx

ATTACHMENT A-SPECIMEN TEST LIST (Estimated Test List subject to change due to programmatic requirements; see PWS)

Estimated

Volume Bldg 10, RM 2C324

# Test Name (12 months) Turnaround Time Methodology daily, after 3pm

Circulating Tumor Cells (CTC) for

Colorectal Cancer by CellSearch, Blood

1 4 days Cell Search System x

!Circulating Tumor Cells (CTC) for

Prostate Cancer by CellSearch, Blood 1 4 days Cell Search System x

Circulating Tumor Cells (CTC) for

Prostate Cancer by CellSearch, Blood 1 4 days Cell Search System x

255 Citrate Excretion, 24 Hour, Urine 138 Same day/1 day Enzymatic x

Citrate Excretion, Pediatric, Random, Urine 3 Same day/1 day Enzymatic x

257 Citric Acid, Serum 1 2 days Spectrophotometry (SP) Enzymatic x

258 CK Isoenzyme Electrophoresis, Serum 22 4 days Electrophoresis, Densitometry x

259 Allergen (IgE), Cladosporium 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

Clomipramine (Anafranil) and

Desmethylclomipramine 1 3 days

Liquid Chromatography/Tandem Mass Spectrometry

(LC/MS/MS)

x

261 Clonazepam (Klonopin), Serum 1 1 day High Performance Liquid Chromatography (HPLC) x

262 Clozapine, Serum 1 3 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

263 Cobalt, Serum 1 1 day Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) x

Cocaine and Metabolite Confirmation, Chain of Custody, Urine 1 2 days

Immunoassay/Gas Chromatography-Mass Spectrometry

(GC-MS)

x

Cocaine and metabolite Confirmation, Urine 1 2 days

Immunoassay/Gas Chromatography-Mass Spectrometry

(GC-MS)

x

Coccidioides Antibody with Reflex, Serum

1 day (Additional days for CF/ID results if reflex testing is required.)

Enzyme Immunoassay (EIA) x

Coccidioides Antibody with Reflex, Spinal Fluid

1 day (Additional days for CF/ID results if reflex testing is required.)

Enzyme Immunoassay (EIA) x

Coccidioides Antibody, Complement

Fixation and Immunodiffusion, Serum 1 1 day Complement Fixation (CF)/Immunodiffusion x

Coccidioides Antibody, Complement

Fixation and Immunodiffusion, Spinal

Fluid

1 1 day Complement Fixation (CF)/Immunodiffusion (ID) x

270 Coccidioides Antibody, Serum 1 4 days Complement Fixation (CF) and Immunodiffusion (ID) x

271 Coccidioides Antibody, Spinal Fluid 1 3 days Complement Fixation (CF)/Immunodiffusion x

272 Coccidioides, Rapid PCR 1

1 day (5 days for paraffin-embedded tissue)

Real-Time Polymerase Chain Reaction (PCR) x

273 Allergen (IgE), Cockroach 39 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

274 Allergen (IgE), Codfish 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

Coenzyme Q10, Reduced and Total, Plasma 1 3 days

High Performance Liquid Chromatography (HPLC) with

Electrochemical Detection x

276 CRMP-5 IgG, Serum 1 3 days if negative;

5 days if positive Indirect Immunofluorescence x

277 CRMP-5-IgG Western Blot, Serum 5 3 days if negative;

5 days if positive Western Blot x

278 CRMP-5-IgG Western Blot, CSF 1 3 days if negative;

5 days if positive Western Blot x

C1q (Complement Component C1q), Serum 3 Same day/1day Nephelometry x

C3 (Third Component of

Complement), Serum 1 Same day/1 day Nephelometry x

C4 (Fourth Component of

Complement), Serum 1 1 day Nephelometry x

Complement, Alternate Pathway

(AH50), Functional, Serum 1 2 days Enzyme-Linked Immunosorbent Assay (ELISA) x

283 Complement, Total, Serum 1 1 day Automated Liposome Lysis Assay x

284 CAH 21-Hydroxylase Profile 1 2 days Liquid Chromatography-Tandem Mass Sprectrometry x

285 CAH 21-Hydroxylase Profile 1 2 days Liquid Chromatography-Tandem Mass Sprectrometry x

Connective Tissue Disease Cascade, Serum 1 3 days

Enzyme-Linked Immunosorbent Assay (ELISA)/Enzyme

Immunoassay (EIA) x

287 Copper, 24 Hour, Urine 15 1 day Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) x

288 Copper, Liver Tissue 1 2 days Inductively Coupled Plasma/Mass Spectrometry (ICP/MS) x

289 Copper, Liver Tissue 1 2 days Inductively Coupled Plasma/Mass Spectrometry (ICP/MS) x

290 Copper, Random, Urine 1 1 day Dynamic Reaction Cell-Inductively Coupled Plasma-Mas

Spectrometry x

291 Copper, Serum 219 1 day Dynamic Reaction Cell Inductively Coupled Plasma Mass

Spectrometry (DRC-ICP-MS) x

292 Copper, Serum 1 1 day Dynamic Reaction Cell Inductively Coupled Plasma Mass

Spectrometry (DRC-ICP-MS) x

293 Corticosterone, Serum 1 3 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

294 Cortisol, Free and Total 1 5 days Liquid Chromatography Tandem Mass Spectrometry

(LS/MS/MS), Equilibrium Dialysis x

295 Cortisol, Free, Urine 24 Hour 23 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

Page 6 Attachment A -Specimen Test 11-4-15 DRAFT.xlsx

ATTACHMENT A-SPECIMEN TEST LIST (Estimated Test List subject to change due to programmatic requirements; see PWS)

Estimated

Volume Bldg 10, RM 2C324

# Test Name (12 months) Turnaround Time Methodology daily, after 3pm

296 Cortisol, Free, Random Urine 3 2 days Liquid Chromatography/Tandem mass Spectrometry

(LC/MS/MS)/Enzymatic x

297 Cortisol, Inferior Vena Cava 1 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

298 Cortisol, Left Adrenal Vein 1 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

299 Cortisol, Right Adrenal Vein 1 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

300 Cortisol, Saliva 48 2 days Liquid Chromatography/Tandem Mass Spectrometry (LC-

MS/MS)

x

301 Cortisol, Serum 1 Same day/1 day Automated Chemiluminescent Immunoenzymatic Assay

System x

302 Cortisol, Serum, LC-MS/MS 1 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

303 Cortisol, Serum, LC-MS/MS 1 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

Cortisol with Cortisone, Free, Urine 24

Hour 1 2 days

Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

Cortisol with Cortisone, Free, Random

Urine 1 2 days

Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)/Enzymatic x

Coxiella burnetii (q Fever), Molecular

Detection, PCR, Blood 1 2 days Real-time Polymerase Chain Reaction (PCR) x

Coxiella burnetii (Q Fever), Molecular

Detection, PCR, Serum 1 2 days Real-Time Polymerase Chain Reaction (PCR) x

Coxsackie A Antibody Panel, CF, Serum 1 2 - 5 days Complement Fixation (CF) x

Coxsackie B Antibody Panel,CF

(Serum) 1 2 - 5 days Complement Fixation (CF) x

310 C-Peptide, Serum 27 Same day/1 day Automated Chemiluminometric Immunoassay x

311 Allergen (IgE), Crab 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

Creatine Kinase (CK) MB Isoenzyme, Serum 4 Same day/1 day Electrochemiluminescent Immunoassay x

313 Creatine Kinase (CK), Serum 4 Same day/1 day Photometric, creatine phosphate + ADP x

Creatine Kinase Isoenzyme Reflex, Serum

1 day-CK Total; 4 days- CK

Isoenzymes

Electrophoresis, Densitometry Photometric, Creatine

Phosphate + ADP x

315 Creatine, (Bill Only), Urine 1 x

316 Creatinine with eGFR (MDRD), P/S 1 Same day/1 day Enzymatic x

317 Creatinine, (Bill Only), Urine 1 x

Cryoglobulin and Cryofibrinogen

Panel, Serum and Plasma 1 2 days

Quantitation and Qualitative Typing. Precipitation at 1 degree C. Includes cryofibrinogen.

x

Cryopreservation For Biochemical

Studies

40-45 days depending on rapidity of growth x

320 Cryptococcus Antigen, Pleural Fluid 1 Same day\1 day Latex Agglutination x

321 Cryptococcus Antigen, Urine 1 1 day Latex Agglutination x

Cutaneous Immunofluorescence

Antibody, IgG, Serum

2 days/7 days-

Herpes

(pemphigoid) gestationis or paraneoplastic pemphigus

Indirect Immunofluorescence x

Cutaneous Immunofluorescence, Biopsy 1 2 days

Direct Immunofluroescence Staining of Cryostat Prepared

Skin Biopsy Sections for IgG, IgM, IgA, C3, and

Fibrinogen Deposition x

324 Cyanide, Blood 1 Same day/1 day Colorimetric x

325 Cyclic AMP, Urinary Excretion 111 2 days High-Pressure Liquid Chromatography (HPLC)/Enzymatic x

Cyclic Citrullinated Peptide (CCP)

Antibodies 1 Same day/1 day Enzyme Immunoassay x

327 Cyclospora Species Detection Stain 1 2 days Safranin Stain of Stool x

328 Cyclosporine, Blood 1 Same day/1 day High-Performance Liquid Chromatography-Tandem Mass

Spectrometry (HPLC-MS/MS) x

Cystic Fibrosis Mutation Analysis, 106-

Mutation Panel 1 6 days multiplex polymermase chain reaction (PCR)-based assay utilizing the Sequenom Mass ARRAY platform x

Cysticercosis, IgG Antibody, Western

Blot Assay, Serum 1 Same day/1 day Western Blot Assay x

Cystinuria Profile, Quantitative, 24 Hr, Urine 1 3 days

Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

Cystinuria Profile, Quantitative, Random 1 3 days

Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

Cytochrome P450 3A4 Genotype, Blood 1 1 day

Polymerase Chain Reaction (PCR) 5'-Nuclease End-Point

Allelic Discrimination Analysis x

334 Cytokine Panel 12 1 1 - 4 days Quantitative Multiplex Bead Assay x

Cytomegalovirus (CMV) Antibodies, IgM and IgG, Serum 1 Same day/1 day Multiplex Flow Immunoassay (MFI) x

336 Cytomegalovirus (CMV) by Rapid PCR 1 1 day/same day Real-Time Polymerase Chain Reaction (PCR)/DNA Probe

Hybridization x

337 Cytomegalovirus (CMV) by Rapid PCR 1 1 day/same day Real-Time Polymerase Chain Reaction (PCR)/DNA Probe

Hybridization x

Cytoplasmic Neutrophil Antibodies

(ANCA), Serum 13 2 days Indirect Immunofluorescence x

339 Allergen (IgE), Dairy and Grain Profile 1 Same day/1 day Fluorescence Enzyme Immunoassay (FEIA) x

Dehydroepiandrosterone (DHEA), Serum 1 2 days LC-MS/MS x

Dehydroepiandrosterone (DHEA), Serum 1 2 days LC-MS/MS x

Dehydroepiandrosterone Sulfate

(DHEA-S), Serum 1 Same day/1 day Competitive Chemiluminescent Immunoassay x

Dementia, Autoimmune Evaluation, Spinal Fluid

3 days if negative/5 days if positive

Indirect Immunofluorescence Assay (IFA);

Radioimmunoassay (RIA); Cell Binding

Assay (CBA); Western Blot (WB)

Page 7 Attachment A -Specimen Test 11-4-15 DRAFT.xlsx

ATTACHMENT A-SPECIMEN TEST LIST (Estimated Test List subject to change due to programmatic requirements; see PWS)

Estimated

Volume Bldg 10, RM 2C324

# Test Name (12 months) Turnaround Time Methodology daily, after 3pm

Dentatorubral-Pallidoluysian Atrophy

(DRPLA) Gene Analysis, Blood 1 5 days

A polymerase chain reaction (PCR) based assay is used to amplify across the region of the DRPLA gene containing the CAG repeats. Assay products are separated by denaturing polyacrylamide gel electrophoresis (sequencing gel) and are sized by comparison with an M13 sequence.

x

345 Deoxycorticosterone (DOC), Serum 1 4 - 8 days

HPLC Tandem Mass Spectrometry x

346 Desmoglein 1 and Desmoglein 3 1 Same day/1 day Enzyme Linked Immunoabsorbant Assay (ELISA) x

347 Dexamethasone 9 3 days HPLC Tandem Mass Spectrometry x

348 Diabetes Mellitus Type 1 Evaluation 1 7 days Radioimmunoprecipitation x

349 Diazepam & Nordiazepam, Serum 1 2 days High-Pressure Liquid Chromatography (HPLC) x

350 Dihydrotestosterone (DHT), Serum 33 2 days Liquid Chromatography Tandem Mass Spectrometry (LC-

MS/MS)

x

DILUTE RUSSEL’S VIPER VENOM

TEST (DRVVT)

1 1 - 7 days Clot x

Diphtheria Toxoid IgG Antibody, Serum 224 Same day/1 day Enzyme Immunoassay (EIA) x

Diphtheria/Tetanus Antibody Panel, Serum 4 Same day/1 day Enzyme Immunoassay (EIA) x

354 Disopyramide, Serum 1 Same day/1 day Enzyme Multiplied Immunoassay Technique (EMIT) x

355 D-Lactate, Plasma 1 4 days Enzymatic x

DNA Double-Stranded (dsDNA)

Antibodies with Reflex, IgG, Serum 1 2 days Enzyme-Linked Immunosorbent Assay (ELISA) x

DNA Double Stranded (ds-DNA)

Antibody, IgG, Serum 12 1 day Enzyme-Linked Immunosorbent Assay (ELISA) x

358 Allergen (IgE), Dog Dander 1 Same day/1 day Fluorescence Enzyme Immunoassay (FEIA) x

359 Doxepin and Nordoxepin, Serum 1 2 days High-Pressure Liquid Chromatography (HPLC) x

Drug Abuse Custom Panel -Chain of

Custody 1 x

Drug Abuse Panel with Confirmation, Chain of Custody, Urine 1 Same day/1 day

Alcohol screened by an Enzymatic Assay All others

Screened by Immunoassay Includes gas chromatography-flame ionization detection (GC-FID) confirmation with quantification for positive alcohol, or gas chromatography-mass spectrometry (GC-MS) x

Drug Abuse Survey with

Confirmation, Panel 9, Chain of

Custody, Urine

1 Same day/1 day

Alcohol Screened by an Enzymatic Assay All Others

Screened by Immunoassay Includes gas chromatography-flame ionization detection( GC-FID) confirmation with quantification for positive alcohol or gas chromatography-mass spectrometry (GC-MS) x

Drug Abuse Survey with

Confirmation, Panel 9, Urine 1 Same day/1 day

Alcohol Screened by an Enzymatic Assay All Others

Screened by Immunoassay Includes gas chromatography-flame ionization detection( GC-FID) confirmation with quantification for positive alcohol or gas chromatography-mass spectrometry (GC-MS) x

Drug Abuse Survey with

Confirmation, Urine 1 Same day/1 day

Alcohol screened by an Enzymatic Assay All others

Screened by Immunoassay Includes gas chromatography-flame ionization detection (GC-FID) confirmation with quantification for positive alcohol, or gas chromatography-mass spectrometry (GC-MS) x

Drug Abuse Survey with

Confirmation, Urine 0 Same day/1 day

Alcohol screened by an Enzymatic Assay All others

Screened by Immunoassay Includes gas chromatography-flame ionization detection (GC-FID) confirmation with quantification for positive alcohol, or gas chromatography-mass spectrometry (GC-MS) x

366 Opiate Confirmation, Urine 1 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

Drug Screen 9 Panel, Serum or

Plasma-Immunoassay Screen with

Reflex to Mass Spectrometry

Confirmatio

1 1 - 4 days Enzyme-Linked Immunosorbent Assay x

Drug Screen, Prescription/OTC, Chain of Custody, Serum 1 2 days Gas Chromatography/Mass Spectrometry (GC/MS). x

Drug Screen, Prescription/OTC, Chain of Custody, Urine 1 3 days Gas-liquid chromatography-mass spectroscopy x

Drug Screen, Prescription/OTC, Serum 48 2 days Gas Chromatography/Mass Spectrometry (GC/MS). x

371 Drug Screen, Prescription/OTC, Urine 60 3 days Gas-liquid chromatography-mass spectroscopy x

372 Duloxetine, Serum 1 1 day/2 days High-Turbulence Liquid Chromatography-Tandem Mass

Spectrometry (HTLC-MS/MS) x

Echinococcus Antibody (IgG), EIA with Reflex to Western Blot 1 1 - 5 days Enzyme Linked Immunosorbent Assay (ELISA) x

374 Echovirus Antibody Panel, CF, Serum 1 2 - 5 days Complement Fixation (CF) x

375 Allergen (IgE), Egg White 2 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

376 Ehrlichia Antibody Panel, Serum 18 Same day/1 day Immunofluorescence Assay (IFA) x

Ehrlichia Chaffeensis (HME) Antibody, IgG, Serum 1 Same day/1 day Immunofluorescence Assay (IFA) x

Ehrlichia / Anaplasma DNA Detection by Rapid PCR, Blood 1 Same day/1 day Rapid Polymerase Chain Reaction (PCR), Blood x

Electrolyte and Osmolality Panel, Feces 7 3 days

Osmotic Gap: Calculation

Sodium, Potassium, and Chloride: Indirect Ion-Selective

Electrode (ISE) Potentiometry

Osmolality: Freezing Point Depression

Phosphorous: Photometric, Ammonium Molybdate

Magnesium: Colorimetric Titration x

Encephalopathy, Autoimmune

Evaluation, Serum

4 days if negative/

7 days if positive

Indirect Immunofluorescence Assay (IFA);

Radioimmunoprecipitation (RIA); Cell

Binding Assay (CBA); Western Blot (WB)

Page 8 Attachment A -Specimen Test 11-4-15 DRAFT.xlsx

ATTACHMENT A-SPECIMEN TEST LIST (Estimated Test List subject to change due to programmatic requirements; see PWS)

Estimated

Volume Bldg 10, RM 2C324

# Test Name (12 months) Turnaround Time Methodology daily, after 3pm

Encephalopathy, Autoimmune

Evaluation, Spinal Fluid

3 days if negative/5 days if positive

Indirect Immunofluorescence Assay (IFA); Cell-Binding

Assay (CBA); Immunoprecipitation Assay;

Radioimmunoassay (RIA); Western Blot x

382 Endomysial (EMA) IgG antibody titer 1 2 days Immunofluorescence (IFA) x

383 Endomysial Antibody, IgA, Serum 103

2 days (not reported on

Saturday or

Sunday)

Indirect Immunofluorescence x

384 Endothelin I 6 14 days Radioimmunoassay (RIA) x

385 E. histolytica Antibody, Serum 2 Same day/1 day Enzyme-Linked Immunosorbent assay (ELISA) x

386 E histolytica Ag 1 1-3 days x

387 Enterovirus by Rapid PCR 14 Same day/1 day LightCycler PCR x

Enterovirus, Molecular Detection, PCR, Plasma 1 Same day/1 day

Real-Time Polymerase Chain Reaction (PCR)/RNA Probe

Hybridization x

389 Eosinophilic Allergen Profile 1 1 - 3 days FEIA x

Epilepsy, Autoimmune Evaluation, Serum

4 days if negative/7 days if positive

Indirect Immunofluorescence Assay (IFA);

Radioimmunoprecipitation (RIA); Cell

Binding Assay (CBA); Western Blot (WB) x

Epilepsy, Autoimmune Evaluation, Spinal Fluid

3 days if negative/5 days if positive

Indirect Immunofluorescence Assay (IFA);

Radioimmunoassay (RIA); Cell Binding

Assay (CBA); Western Blot (WB) x

Epstein-Barr Virus Antibody Profile, Serum 81 Same day/1 day Multiplex flow immunoassay x

Epstein-Barr Virus (EBV), IgG

Antibody to Early Antigen, Serum 1 Same day/1 day Multiplex flow immunoassay x

Epstein-Barr Virus (EBV) Detection by

Rapid PCR

Monday through

Friday: 2 days

Saturday and

Sunday: 3 days

Real-Time Polymerase Chain Reaction (PCR)/DNA Probe

Hybridization x

Epstein-Barr Virus (EBV) Quantitation by Rapid PCR, Blood 1 Same day/1 day

Real-Time Polymerase Chain Reaction (PCR)/DNA Probe

Hybridization x

396 Erythropoietin (EPO), Serum 141 1 day Automated Immunochemiluminometric Assay (ICMA-

DPC)

x

397 Estradiol, Serum 4 2 days Liquid Chromatography/Tandem Mass Spectrometry (LC-

MS/MS)

x

398 Estriol, Unconjugated, Serum 84 Same day/1 day Immunoenzymatic Assay x

Estrogens, E1+ E2, Fractionated, Serum 3 2 days

Liquid Chromatography/Tandem Mass Spectrometry (LC-

MS/MS)

x

400 Estrone, Serum 2 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

401 Ethanol, Blood 24 Same day/1 day Headspace Gas Chromatography-Flame Ionization

Detector (HSGC-FID) x

402 Ethanol, Blood 1 Same day/1 day Headspace Gas Chromatography-Flame Ionization

Detector (HSGC-FID) x

403 Ethanol, Chain of Custody, Blood 1 Same day/1 day Headspace Gas Chromatography-Flame Ionization

Detector (HSGC-FID) x

404 Ethanol, Chain of Custody, Urine 1 x

405 Ethanol, Urine 1 1 day Gas-Liquid Chromatography (GLC) x

406 Ethosuximide, Serum 1 Same day/1 day Enzyme-Multiplied Immunoassay Technique (EMIT) x

407 Allergen (IgE), Ethylene Oxide 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

408 Everolimus, Blood 25 Same day/1 day High-Performance Liquid Chromatography-Tandem Mass

Spectrometry (HPLC-MS?MS) x

409 F2-Isoprostanes, Urine 3 2 days Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS)

x

410 F-Actin Ab, IgG, Serum 1 1 day Enzyme-Linked Immunosorbent Assay (ELISA) x

Familial Adenomatous Polyposis (FAP)

Known Mutation DNA Analysis 1 10 days

DNA Sequencing or Dosage Analysis by Multiplex Ligation-

Dependent Probe Amplification (MLPA) x

Familial Adenomatous Polyposis (FAP)

Screen 1 14 days

Custom Sequence Capture and Targeted Next Generation

Sequencing followed by Polymerase Chain Reaction

(PCR) and Sanger Sequencing and Gene Dosage Analysis by MLPA.

x

Familial Hiberian Fever; TNF-Receptor-

Associated Periodic Syndrome

(TRAPS)

1 4 - 6 weeks Polymerase chain Reaction (PCR) Amplification/DNA

Sequencing x

414 Fat, Feces 56 1 day Nuclear Magnetic Resonance Spectrometer (NMR) x

Fatty Acid Oxidation Assay, Fibroblast

Culture

15 to 71 days depending on rapidity of growth

Fibroblasts incubated with enriched medium followed by

MS/MS acylcarnitine analysis x

Fatty Acid Profile, Comprehensive C8-

C26, Serum 9 4 days

Stable Isotope Dilution Gas Chromatography/Mass

Spectrometry (GC/MS) x

417 Fatty Acid Profile, Essential, C12-C22 118 4 days Stable Isotope Dilution Gas Chromatography/Mass

Spectrometry (GC/MS) x

Fatty Acid Profile, Peroxisomal, C22-

C26, Serum 47 4 days

Stable Isotope Dilution Gas Chromatography/Mass

Spectrometry (GC/MS) x

419 FBN1, Full Gene Sequence 1 7 days Polymerase Chain Reaction (PCR) Followed by DNA

Sequence Analysis x

Fibrinogen Immunofluorescent Stain, Renal 1 1 day Immunohistology (Immunofluorescence) x

421 Fibroblast Culture 1

40-45 days depending on rapidity of growth

Cultivated from Biopsy as Monolayer x

422 Fibroblast Growth Factor 23, Plasma 23 1 day Immunometric ELISA x

423 Filaria IgG4 Antibody, ELISA 1 1 - 8 days Enzyme-Linked Immunosorbent Assay (ELISA) x

424 Allergen (IgE), Fire Ant 1 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

425 FLT3 ITD and TKD Mutation Assay 1 3 - 7 days Multiplex PCR and Capillary Electrophoresis

Page 9 Attachment A -Specimen Test 11-4-15 DRAFT.xlsx

ATTACHMENT A-SPECIMEN TEST LIST (Estimated Test List subject to change due to programmatic requirements; see PWS)

Estimated

Volume Bldg 10, RM 2C324

# Test Name (12 months) Turnaround Time Methodology daily, after 3pm

426 Fluconazole, Serum 2 2 days

Liquid Chromatography-Tandem Mass Spectrometry (LC-

MS/MS) x

427 Fluoride, Plasma 82 1 day Ion-Selective Electrode (ISE) x

428 Fluoxetine, Serum 1 1 day/2 days High-Turbulence Liquid Chromatography -Tandem Mass

Spectrometry (HTLC-MS/MS) x

429 Folate, Serum 1 Same Day/1 day Chemiluminometric Immunoassay x

430 Follicle Stimulating Hormone (FSH) 20 Electrochemiluninescent Technology (ECL) x

Follicle-Stimulating Hormone (FSH), Serum 1 Same day/1 day Immunoenzymatic Assay x

432 Multi-Allergen (IgE), Food Panel 6 Same day/1 day Pharmacia CAP System Fluorescence Enzyme

Immunoassay (FEIA) x

Multi-Allergen (IgE), Food Nut Panel

#1 1 Same day/1 day

Solid phase, Enzyme Immunoassay (Parmacia

Immunocap System) x

Multi-Allergen (IgE), Food Nut Panel

#2 1 Same day/1 day

Solid phase, Enzyme Immunoassay (Parmacia

Immunocap System) x

Multi-Allergen (IgE), Food Seafood

Panel 1 Same day/1 day

Solid phase, Enzyme Immunoassay (Parmacia

Immunocap System) x

Fragile X Syndrome, Molecular

Analysis 30 8 days Polymerase Chain Reaction (PCR) x

Fragile X Syndrome, Molecular

Analysis 1 8 days Polymerase Chain Reaction (PCR) x

438 Fragile X, Follow up Analysis 1 Southern Blot x

FRANCISELLA TULARENSIS

ANTIBODY, DA

1 1-4 days DIRECT AGGLUTINATION (DA) x

440 Free Fatty Acids,Total, Serum 2 1 day Enzymatic Colorimetric x

441 Fructosamine, Serum 63 Same day/1 day Colorimetric Rate Reaction x

442 Full Environmental Panel 1 x

443 Fungitell, Serum 1 1 day Limulus Amebocyte Lysate (LAL) Pathway x

444 Gabapentin, Serum 2 Same day/1 day

Liquid Chromatography - Tandem Mass Spectrometry (LC-

MS/MS) x

445 Gadolinium, Tissue-Dermal 1 2 days Inductively Coupled Plasma Mass Spectrometry x

446 Galactocerebrosidase, Fibroblasts 1

30-45 days depending on rapidity of growth

Radioisotopic x

447 Galactocerebrosidase, Leukocytes 1 9 days Radioisotopic x

448 Galactose, QN, Urine 1 8 days Spectrophotometric, Kinetic x

Ganglionic Acetylcholine Receptor

(Alpha3) Autoantibody, Serum 1 4 days Radioimmunoassay x

450 Ganglioside Antibody Panel, Serum 7 3 days Quantitative Enzyme-Linked Immunosorbent Assay

(ELISA)

x

451 Ganglioside GQ1B Antibody IgG, EIA 1 4 days Enzyme Immunoassay (EIA) x

452 Gastric Inhibitory Polypeptide (GIP) 1 14 days Direct Radioimmunoassay (RIA) x

453 Gastrin, Serum 365 Same day/1 day Automated Chemiluminescent Immunometric Assay x

454 Gastrin, Serum 1 Same day/1 day Automated Chemiluminescent Immunometric Assay x

Gelsolin (GSN) Gene, Full Gene

Analysis 1 14 days

Polymerase Chain Reaction (PCR) Followed by DNA

Sequence Analysis x

Germ Cell Tumor (GCT), Isochromosome 12p, FISH, Tissue 1 7 10 days Fluorescence In Situ Hybridization (FISH) x

457 Ghrelin Total, Plasma 1 5 - 7 days Radioimmunoassay (RIA) x

458 Giardia Antigen, Feces 16 Same day/1 day Enzyme-Linked Immunosorbent Assay (ELISA) x

459 Giardia Antigen, Feces 1 Same day/1 day Enzyme-Linked Immunosorbent Assay (ELISA) x

Gliadin (Deamidated) Antibodies

Evaluation, IgG and IgA, Serum 96 1 day Enzyme-Linked Immunosorbent Assay (ELISA) x

Gliadin (Deamidated) Antibodies, IgA, Serum 1 1 day Enzyme-Linked Immunosorbent Assay (ELISA) x

Gliadin (Deamidated)Antibodies, IgG, Serum 1 1 day Enzyme-Linked Immunosorbent Assay (ELISA) x

Glomerular Basement Membrane

Antibody, IgG, Serum 3 Same day/1 day Multiplex Flow Immunoassay x

464 Glucagon, Plasma 523 2 days Extraction followed by immunoassay x

Glucose-6-Phosphate Dehydrogenase

(G-6-PD) QN, Erythrocytes 1 1 day Kinetic Spectrophotometry (SP) x

Glutamic Acid Decarboxylase (GAD65)

Ab Assay, Serum

2 days/negative 3 days/positive Radioimmunoassay (RIA) x

Glutamic Acid Decarboxylase (GAD65)

Antibody Assay, Spinal Fluid

2 days/negative 3 days/positive Radioimmunoprecipitation Assay x

468 Glutathione, Blood 1 10 days Spectrophotometry x

469 GlycoMark™ 1 Enzymatic, Colorimetric Assay x

470 Gomori's Stain for Iron 1 2 days x

Gonadotropin Releasing Hormone (Gn-

RH)

1 5-7 days Direct Radioimmunoassay (RIA) x

472 Granulocyte Antibodies, Serum 1 7 days Indirect Immunofluorescence x

473 Multi-Allergen (IgE), Grass Panel #2 1 Same day/1 day Solid phase, Enzyme Immunoassay (Parmacia

Immunocap System) x

Growth Hormone Binding Protein

(GHBP)

1 3 - 16 days Ligand binding immunoprecipitation assay x

Growth Hormone-Releasing Hormone

(GH-RH)

1 5-7 days Direct Radioimmunoassay (RIA) x

476 Guanidinoacetate, (Bill Only), Urine 1 10 - 18 days LC-MS/MS x

477 Helicobacter Pylori Breath Test Kit 1 Same Day/1 day Infrared Spectrophotometry x

478 Haemophilus influenzae B Ab, IgG, S 257 Same…